Cancer Discovery

259.7k citations
2.1k papers · · active since 2016

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Cancer Cells and Metastasis
    • Cancer Genomics and Diagnostics

Papers in

    • Cancer Genomics and Diagnostics 268
    • Cancer Immunotherapy and Biomarkers 179
    • CAR-T cell therapy research 143

Cancer Discovery

1.8k papers receiving 223.5k citations

Peers

Cancer Discovery
Comparison fields: 5 of 211
  • Oncology 104.4k
  • Cancer Research 53.6k
  • Immunology 38.8k
  • Molecular Biology 112.5k
  • Pulmonary and Respiratory Medicine 48.5k
Replace Nature Reviews Clinical Oncology with:
Nature Reviews Clinical Oncology United States
Journal of Hematology & Oncology China
Seminars in Cancer Biology United States
Cell Research China
Cancer Treatment Reviews United States
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer United States
Cancer and Metastasis Reviews United States
Signal Transduction and Targeted Therapy China
Neoplasia United States
Molecular Cancer Research United States
Cancer Discovery relative to Nature Reviews Clinical Oncology United States Nature Reviews Clinical Oncology's profile →
Citations per field
00.5×1.5×
Nature Reviews Clinical Oncology · 1×
Citations per year

Countries where authors publish in Cancer Discovery

Since Specialization
Citations

This map shows the geographic impact of research published in Cancer Discovery. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Cancer Discovery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cancer Discovery more than expected).

Fields of papers published in Cancer Discovery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Cancer Discovery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Cancer Discovery.

About Cancer Discovery

The 2.1k papers published in Cancer Discovery in the last decades have received a total of 259.7k indexed citations . Papers published in Cancer Discovery usually cover Cancer Research (422 papers), Oncology (743 papers), Immunology (267 papers), Molecular Biology (838 papers) and Genetics (108 papers) specifically the topics of Cancer Genomics and Diagnostics (268 papers), Cancer Immunotherapy and Biomarkers (179 papers), CAR-T cell therapy research (143 papers), Lung Cancer Treatments and Mutations (133 papers), Epigenetics and DNA Methylation (129 papers), Melanoma and MAPK Pathways (97 papers), Immunotherapy and Immune Responses (94 papers) and Acute Myeloid Leukemia Research (92 papers). The most active scholars publishing in Cancer Discovery are Nikolaus D. Schultz, Chris Sander, Ethan G Cerami, James Patrick Allison, Benjamin E Gross, Erik Larsson, Boris A. Reva, Bülent Arman Aksoy, Michael Heuer and Jianjiong Gao.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact